MESOBLAST LTD
MESONasdaq
$17.32
↓ -3.0%Jul 17 close · end-of-day
Price
1Y↑ +52.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
No screener snapshot for this ticker.
Company profile
Mesoblast Limited offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its products under the Phase III clinical trials include remestemcel-L for the treatment of steroid refractory acute graft versus host disease, as well as acute respiratory distress syndrome due to COVID-19 infection. The company has strategic partnerships with Tasly Pharmaceutical Group, JCR Pharmaceuticals Co. Ltd. and Grünenthal.
- CEO
- Silviu Itescu
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 80
- Website
- mesoblast.com
Earnings
No reported earnings periods on file.
Financial statements
No annual data.
No quarterly data.
Company news
Jul 17, 2026
Jul 10, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-04-10 | George Gregory | Buy | 2,324,072 | $1.48 | $3.4M | filing |
| 2026-04-10 | George Gregory | Buy | 2,324,072 | $1.48 | $3.4M | filing |
| 2026-04-09 | George Gregory | Buy | 500,000 | $14.39 | $7.2M | filing |
| 2026-04-09 | George Gregory | Buy | 500,000 | $14.39 | $7.2M | filing |
| 2026-04-09 | George Gregory | Buy | 886,890 | $1.43 | $1.3M | filing |
| 2026-04-09 | George Gregory | Buy | 886,890 | $1.43 | $1.3M | filing |
| 2026-04-09 | George Gregory | Buy | 500,000 | $1.44 | $720,000.00 | filing |
| 2026-04-09 | George Gregory | Buy | 20,000 | $14.30 | $286,000.00 | filing |
| 2026-04-09 | George Gregory | Buy | 105,000 | $1.46 | $153,300.00 | filing |
| 2026-04-09 | George Gregory | Buy | 10,000 | $14.40 | $144,000.00 | filing |
| 2026-04-09 | George Gregory | Buy | 10,000 | $14.30 | $143,000.00 | filing |
| 2026-04-09 | George Gregory | Buy | 10,000 | $14.30 | $143,000.00 | filing |
| 2026-04-09 | George Gregory | Buy | 10,000 | $14.30 | $143,000.00 | filing |
| 2026-04-09 | George Gregory | Buy | 10,000 | $14.25 | $142,500.00 | filing |
| 2026-04-09 | George Gregory | Buy | 10,000 | $14.10 | $141,000.00 | filing |
| 2026-04-09 | George Gregory | Buy | 5,240 | $14.25 | $74,670.00 | filing |
| 2026-04-09 | George Gregory | Buy | 5,000 | $14.30 | $71,500.00 | filing |
| 2026-04-09 | George Gregory | Buy | 4,760 | $14.40 | $68,544.00 | filing |
| 2026-04-09 | George Gregory | Buy | 20,000 | $1.43 | $28,600.00 | filing |
| 2026-04-09 | George Gregory | Buy | 10,000 | $1.44 | $14,400.00 | filing |
| 2026-04-09 | George Gregory | Buy | 10,000 | $1.43 | $14,300.00 | filing |
| 2026-04-09 | George Gregory | Buy | 10,000 | $1.43 | $14,300.00 | filing |
| 2026-04-09 | George Gregory | Buy | 10,000 | $1.43 | $14,300.00 | filing |
| 2026-04-09 | George Gregory | Buy | 10,000 | $1.43 | $14,300.00 | filing |
| 2026-04-09 | George Gregory | Buy | 10,000 | $1.41 | $14,100.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.